Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00012701
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2001-03-14
Brief Title:
Measuring HIV Quality of Care
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Measuring HIV Quality of Care
Status:
COMPLETED
Status Verified Date:
2005-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The VA is the largest single provider of HIV care in the United States The late 1990s have seen a revolution in the quality standards for this disease with the onset of Highly Active Antiretroviral Therapy HAART and other developments
Detailed Description:
Background
The VA is the largest single provider of HIV care in the United States The late 1990s have seen a revolution in the quality standards for this disease with the onset of Highly Active Antiretroviral Therapy HAART and other developments
Objectives
Our purpose in this project is to develop a method for assessing quality in two important areas of HIV care - antiretroviral medications and opportunistic infection screening and prophylaxis - and explore the determinants of high quality care in order to suggest quality improvement strategies
Methods
The analysis has four parts First it will describe the level of adherence to the indicators in VA HIV patients nationwide and compare VA HIV patients to national benchmarks Second it will analyze facility and patient level predictors of adherence to indicators of quality of care and compare them with the predictors in the non VA population using staged logistic regressions Third it will seek to validate certain indicators eg HAART therapy against clinical outcomes like hospitalization and immune status We will also model the clinical price that the VA pays in suboptimal clinical outcomes as a result of current performance levels Fourth we will compare the performance of the facilities after one year of an intensive targeted indicator-specific feedback group versus those receiving aggregate data only
Status
Data analysis
The VA is the largest single provider of HIV care in the United States The late 1990s have seen a revolution in the quality standards for this disease with the onset of Highly Active Antiretroviral Therapy HAART and other developments
Objectives
Our purpose in this project is to develop a method for assessing quality in two important areas of HIV care - antiretroviral medications and opportunistic infection screening and prophylaxis - and explore the determinants of high quality care in order to suggest quality improvement strategies
Methods
The analysis has four parts First it will describe the level of adherence to the indicators in VA HIV patients nationwide and compare VA HIV patients to national benchmarks Second it will analyze facility and patient level predictors of adherence to indicators of quality of care and compare them with the predictors in the non VA population using staged logistic regressions Third it will seek to validate certain indicators eg HAART therapy against clinical outcomes like hospitalization and immune status We will also model the clinical price that the VA pays in suboptimal clinical outcomes as a result of current performance levels Fourth we will compare the performance of the facilities after one year of an intensive targeted indicator-specific feedback group versus those receiving aggregate data only
Status
Data analysis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None